IP Library Granted Patent US 9,822,402
Granted Patent B2
US 9,822,402 · App. 14/388,704 · Granted Nov 21, 2017

Internal control nucleic acids for amplification

Inventors: Keith Thornton (Owings Mills, MD); Danielle Koffenberger (Stewartstown, PA); Paul Madepogu (Baltimore, MD)
Assignee: BECTON, DICKINSON AND COMPANY
C12Q1/6853C12Q1/6876C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,822,402
App. No.
14/388,704
Granted
Nov 21, 2017
Kind
B2
Abstract

Nucleic acids sequences that can be used for nucleic acid amplification, for example quantitative nucleic acid amplification, are provided herein.

Claims (16)

1. A method for quantifying the amount of a polynucleotide in a sample, the method comprising:

combining a quantity of the polynucleotide with the sample, the polynucleotide comprising a sequence at least about 97% identical to the sequence of SEQ ID NO: 1;

contacting the polynucleotide with a forward primer and a reverse primer, wherein the forward primer comprises an oligonucleotide at least about 85% identical to SEQ ID NO: 3 or 5, and wherein the reverse primer comprises an oligonucleotide at least about 85% identical to SEQ ID NO: 4 or 6;

extending the forward primer and reverse primer, thereby producing at least one target amplicon; and

detecting a signal proportional to the quantity of the at least one target amplicon.

2. The method of claim 1 , wherein the forward primer is at least about 95% identical to SEQ ID NO: 3.

3. The method of claim 1 , wherein the reverse primer is at least about 95% identical to SEQ ID NO: 4.

4. The method of claim 1 , wherein the forward primer comprises SEQ ID NO: 3, and the reverse primer comprises SEQ ID NO: 4.

5. The method of claim 1 , wherein the forward primer comprises SEQ ID NO: 5, and the reverse primer comprises SEQ ID NO: 6.

6. The method of claim 1 , wherein detecting a signal proportional to the quantity of the at least one target amplicon comprises contacting the amplicon with a single-stranded oligonucleotide probe that anneals to the amplicon at a temperature of at least 50° C., wherein the probe is configured to emit a detectable signal following hybridization to a substantially complementary nucleic acid, but to not emit the detectable signal when it is single-stranded.

7. The method of claim 6 , wherein the single-stranded oligonucleotide probe comprises a sequence at least about 95% identical to SEQ ID NO: 2, or the reverse complement thereof.

8. The method of claim 6 , wherein the single-stranded oligonucleotide probe further comprises a least one fluorophore, and at least one quencher.

9. The method of claim 1 , further comprising extracting nucleic acid from the sample, wherein the polynucleotide is combined with the sample prior to extracting nucleic acid from the sample.

10. The method of claim 1 , wherein extending the forward primer and reverse primer comprises at least one of polymerase chain reaction (PCR), strand displacement amplification (SDA), loop-mediated isothermal amplification (LAMP), ligase chain reaction (LCR), immuno-amplification, transcription-mediated amplification (TMA), nucleic acid sequence based amplification (NASBA), self-sustained sequence replication (3SR), and rolling circle amplification.

11. The method of claim 1 , wherein the forward primer is at least about 95% identical to SEQ ID NO: 5.

12. The method of claim 1 , wherein the reverse primer is at least about 95% identical to SEQ ID NO: 6.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2017
From: THORNTON, KEITH; KOFFENBERGER, DANIELLE; MADEPOGU, PAUL
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 043828/0799 →
Continuity (2)
Provisional Application 61617562 · Mar 29, 2012
Related Publication 20150050651A1 · Feb 19, 2015